AOA-backed DOC Access Act gains U.S. Senate companion
AOA turning up pressure on anti-patient, anti-doctor vision plan abuses with new U.S. Senate companion legislation.
AOA turning up pressure on anti-patient, anti-doctor vision plan abuses with new U.S. Senate companion legislation.
Over 7,400 individual constituent letters were sent via AOA’s Action Center and countless phone calls placed to senators’ offices, in what represents the AOA’s largest advocacy campaign in recent history.
AOA and optometry’s advocates continue to fight the FTC’s rule changes—act now to support these efforts and have your practice ready for implementation on day one.
The company has recalled its AquaSoft brand of contacts because of a manufacturing defect that may cause eye discomfort and irritation.
FTC rule set to take effect in October.
The FTC’s Contact Lens Rule, COVID-19 pandemic response and vision plan concerns headline the advocacy priorities that doctors nationwide shared with Congress in a consequential session.
The AOA continues to create opportunities for paraoptometrics to be all they can be—readying them for the effects of scope expansion and empowering them as grassroots advocates for the profession of optometry. And for the first time, paraoptometrics can join the single-largest annual advocacy event and the centerpiece of the profession's national lobbying efforts.
In firsts, AOA on Capitol Hill 2020 will be virtual and include advocacy-minded doctors, optometry students and paraoptometrics. The registration deadline is Sept. 4.
The AOA and doctors are acting quickly to enlist federal legislators to join the growing mass of voices asserting concerns regarding the new amendment to the Contact Lens Rule announced by the FTC.
Some doctors of optometry are billing claims with modifiers 24 and 25 at a higher rate than other eye care providers.